Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 5—May 2023
CME ACTIVITY - Research

Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021

Lillie M. Powell, Soo Jeon Choi, Chloe E. Chipman, Megan E. Grund, P. Rocco LaSala1, and Slawomir Lukomski1Comments to Author 
Author affiliation: West Virginia University, Morgantown, West Virginia, USA

Main Article

Table 2

Proposed aminoglycoside and tetracycline resistance determinants in group A Streptococcus isolates, West Virginia, USA, 2020–2021

emm type Kanamycin resistance Streptomycin resistance Tetracycline resistance Determinant Resistance element Reference
emm92
 +
 +
 +
 ICESpyM92, Tn916 Tet(M), ant (6)-Ia, aph-(3′)-III (5)
pRW35
 ermT
 (15)
emm11
 + – + Tn6003-like Tet(M), ermB, aph(3′)-III (5)
– – + Tn6002 Tet(M), ermB (5)
+
 –
 +
 ICESp2905
 Tet(O), ermA, aph-(3′)-III
 (21)
emm197
 –
 –
 +
 ICESp2905
 Tet(O), ermA
 (21)
emm22 – – + Tn1207.1-like Tet(O), mefA, (20)

Main Article

References
  1. Stevens  DL. Invasive group A streptococcus infections. Clin Infect Dis. 1992;14:2–11. DOIPubMedGoogle Scholar
  2. Carapetis  JR, Beaton  A, Cunningham  MW, Guilherme  L, Karthikeyan  G, Mayosi  BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. DOIPubMedGoogle Scholar
  3. Walker  MJ, Barnett  TC, McArthur  JD, Cole  JN, Gillen  CM, Henningham  A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301. DOIPubMedGoogle Scholar
  4. Silva-Costa  C, Friães  A, Ramirez  M, Melo-Cristino  J. Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies. Expert Rev Anti Infect Ther. 2015;13:615–28. DOIPubMedGoogle Scholar
  5. Sanson  MA, Macias  OR, Shah  BJ, Hanson  B, Vega  LA, Alamarat  Z, et al. Unexpected relationships between frequency of antimicrobial resistance, disease phenotype and emm type in group A Streptococcus. Microb Genom. 2019;5:e000316. DOIPubMedGoogle Scholar
  6. Mingoia  M, Morici  E, Morroni  G, Giovanetti  E, Del Grosso  M, Pantosti  A, et al. Tn5253 family integrative and conjugative elements carrying mef(I) and catQ determinants in Streptococcus pneumoniae and Streptococcus pyogenes. Antimicrob Agents Chemother. 2014;58:5886–93. DOIPubMedGoogle Scholar
  7. Berbel  D, Càmara  J, García  E, Tubau  F, Guérin  F, Giard  JC, et al. A novel genomic island harbouring lsa(E) and lnu(B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics. Int J Antimicrob Agents. 2019;54:647–51. DOIPubMedGoogle Scholar
  8. Centers for Disease Control and Prevention. Erythromycin-resistant group A Streptococcus [cited 2021 Nov 23]. https://www.cdc.gov/drugresistance/pdf/threats-report/gas-508.pdf
  9. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs): Emerging Infections Program network, group A Streptococcus, 2010 [cited 2012 Jan 5]. https://www.cdc.gov/abcs/reports-findings/survreports/gas10.html
  10. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report: Emerging Infections Program network, group A Streptococcus, 2019 [cited 2022 Jun 16]. https://www.cdc.gov/abcs/downloads/GAS_Surveillance_Report_2019.pdf
  11. Fay  K, Onukwube  J, Chochua  S, Schaffner  W, Cieslak  P, Lynfield  R, et al. Patterns of antibiotic nonsusceptibility among invasive group A Streptococcus infections—United States, 2006–2017. Clin Infect Dis. 2021;73:1957–64. DOIPubMedGoogle Scholar
  12. Bruun  T, Rath  E, Madsen  MB, Oppegaard  O, Nekludov  M, Arnell  P, et al.; INFECT Study Group. Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study. Clin Infect Dis. 2021;72:293–300. DOIPubMedGoogle Scholar
  13. Centers for Disease Control and Prevention. 2020 drug overdose death rates [cited 2022 Jul 27]. https://www.cdc.gov/drugoverdose/deaths/2020.html
  14. Goldenberger  D, Perschil  I, Ritzler  M, Altwegg  M. A simple “universal” DNA extraction procedure using SDS and proteinase K is compatible with direct PCR amplification. PCR Methods Appl. 1995;4:368–70. DOIPubMedGoogle Scholar
  15. Woodbury  RL, Klammer  KA, Xiong  Y, Bailiff  T, Glennen  A, Bartkus  JM, et al.; Active Bacterial Core Surveillance Team. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains. Antimicrob Agents Chemother. 2008;52:1140–3. DOIPubMedGoogle Scholar
  16. Beall  B, Facklam  R, Thompson  T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996;34:953–8. DOIPubMedGoogle Scholar
  17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 31st ed. CLSI supplement M100. Wayne (PA): The Institute; 2021.
  18. Musser  JM, Hauser  AR, Kim  MH, Schlievert  PM, Nelson  K, Selander  RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A. 1991;88:2668–72. DOIPubMedGoogle Scholar
  19. Jain  I, Sarkar  P, Danger  JL, Medicielo  J, Roshika  R, Calfee  G, et al. A mobile genetic element promotes the association between serotype M28 group A Streptococcus isolates and cases of puerperal sepsis. J Infect Dis. 2019;220:882–91. DOIPubMedGoogle Scholar
  20. Blackman Northwood  J, Del Grosso  M, Cossins  LR, Coley  MD, Creti  R, Pantosti  A, et al. Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005. Antimicrob Agents Chemother. 2009;53:1921–5. DOIPubMedGoogle Scholar
  21. Giovanetti  E, Brenciani  A, Lupidi  R, Roberts  MC, Varaldo  PE. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. Antimicrob Agents Chemother. 2003;47:2844–9. DOIPubMedGoogle Scholar
  22. Valenciano  SJ, Onukwube  J, Spiller  MW, Thomas  A, Como-Sabetti  K, Schaffner  W, et al. Invasive group A streptococcal infections among people who inject drugs and people experiencing homelessness in the United States, 2010–2017. Clin Infect Dis. 2021;73:e3718–26. DOIPubMedGoogle Scholar
  23. Chochua  S, Metcalf  BJ, Li  Z, Rivers  J, Mathis  S, Jackson  D, et al. Population and whole genome sequence based characterization of invasive group A streptococci recovered in the United States during 2015. MBio. 2017;8:e01422–17. DOIPubMedGoogle Scholar
  24. Li  Y, Rivers  J, Mathis  S, Li  Z, Velusamy  S, Nanduri  SA, et al. Genomic surveillance of Streptococcus pyogenes strains causing invasive disease, United States, 2016–2017. Front Microbiol. 2020;11:1547. DOIPubMedGoogle Scholar
  25. Le Hello  S, Doloy  A, Baumann  F, Roques  N, Coudene  P, Rouchon  B, et al. Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever. [Erratum in: J Clin Microbiol. 2010;48:1993]. J Clin Microbiol. 2010;48:526–30. DOIPubMedGoogle Scholar
  26. Abraham  T, Sistla  S. Molecular epidemiology of macrolide resistant Group A streptococci from Puducherry, India. J Infect Dev Ctries. 2017;11:679–83. DOIPubMedGoogle Scholar
  27. Dale  JB, Penfound  TA, Chiang  EY, Walton  WJ. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine. 2011;29:8175–8. DOIPubMedGoogle Scholar
  28. Palmieri  C, Magi  G, Creti  R, Baldassarri  L, Imperi  M, Gherardi  G, et al. Interspecies mobilization of an ermT-carrying plasmid of Streptococcus dysgalactiae subsp. equisimilis by a coresident ICE of the ICESa2603 family. J Antimicrob Chemother. 2013;68:23–6. DOIPubMedGoogle Scholar
  29. Kadlec  K, Schwarz  S. Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain. Antimicrob Agents Chemother. 2010;54:915–8. DOIPubMedGoogle Scholar
  30. DiPersio  LP, DiPersio  JR, Beach  JA, Loudon  AM, Fuchs  AM. Identification and characterization of plasmid-borne erm(T) macrolide resistance in group B and group A Streptococcus. Diagn Microbiol Infect Dis. 2011;71:217–23. DOIPubMedGoogle Scholar
  31. Ksia  S, Smaoui  H, Hraoui  M, Bouafsoun  A, Boutiba-Ben Boubaker  I, Kechrid  A. Molecular characteristics of erythromycin-resistant Streptococcus pyogenes strains isolated from children patients in Tunis, Tunisia. Microb Drug Resist. 2017;23:633–9. DOIPubMedGoogle Scholar
  32. Bocking  N, Matsumoto  CL, Loewen  K, Teatero  S, Marchand-Austin  A, Gordon  J, et al. High incidence of invasive group A streptococcal infections in remote indigenous communities in Northwestern Ontario, Canada. Open Forum Infect Dis. 2016;4:ofw243. DOIPubMedGoogle Scholar
  33. Meehan  M, Murchan  S, Gavin  PJ, Drew  RJ, Cunney  R. Epidemiology of an upsurge of invasive group A streptococcal infections in Ireland, 2012-2015. J Infect. 2018;77:183–90. DOIPubMedGoogle Scholar
  34. Hasegawa  T, Hata  N, Matsui  H, Isaka  M, Tatsuno  I. Characterisation of clinically isolated Streptococcus pyogenes from balanoposthitis patients, with special emphasis on emm89 isolates. J Med Microbiol. 2017;66:511–6. DOIPubMedGoogle Scholar
  35. Shen  Y, Cai  J, Davies  MR, Zhang  C, Gao  K, Qiao  D, et al. Identification and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes clones harboring tetracycline and macrolide resistance in Shanghai, China. Front Microbiol. 2018;9:542. DOIPubMedGoogle Scholar
  36. Zhu  L, Olsen  RJ, Nasser  W, de la Riva Morales  I, Musser  JM. Trading capsule for increased cytotoxin production: contribution to virulence of a newly emerged clade of emm89 Streptococcus pyogenes. MBio. 2015;6:e01378–15. DOIPubMedGoogle Scholar
  37. Turner  CE, Abbott  J, Lamagni  T, Holden  MT, David  S, Jones  MD, et al. Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom. MBio. 2015;6:e00622. DOIPubMedGoogle Scholar
  38. Wajima  T, Chiba  N, Morozumi  M, Shouji  M, Sunaoshi  K, Sugita  K, et al.; GAS Surveillance Study Group. Prevalence of macrolide resistance among group A streptococci isolated from pharyngotonsillitis. Microb Drug Resist. 2014;20:431–5. DOIPubMedGoogle Scholar
  39. Turner  CE, Holden  MTG, Blane  B, Horner  C, Peacock  SJ, Sriskandan  S. The emergence of successful Streptococcus pyogenes lineages through convergent pathways of capsule loss and recombination directing high toxin expression. MBio. 2019;10:e02521–19. DOIPubMedGoogle Scholar
  40. Vega  LA, Sanson  MA, Cubria  MB, Regmi  S, Shah  BJ, Shelburne  SA, et al. The integrative conjugative element ICESpyM92 contributes to pathogenicity of emergent antimicrobial-resistant emm92 group A Streptococcus. Infect Immun. 2022;90:e0008022. DOIPubMedGoogle Scholar
  41. Partridge  SR, Kwong  SM, Firth  N, Jensen  SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31:e00088–17. DOIPubMedGoogle Scholar
  42. Chancey  ST, Bai  X, Kumar  N, Drabek  EF, Daugherty  SC, Colon  T, et al. Transcriptional attenuation controls macrolide inducible efflux and resistance in Streptococcus pneumoniae and in other Gram-positive bacteria containing mef/mel(msr(D)) elements. PLoS One. 2015;10:e0116254. DOIPubMedGoogle Scholar
  43. Metcalf  B, Nanduri  S, Chochua  S, Li  Y, Fleming-Dutra  K, McGee  L, et al. Cluster transmission drives invasive group A Streptococcus disease within the United States and is focused on communities experiencing disadvantage. J Infect Dis. 2022;226:546–53. DOIPubMedGoogle Scholar
  44. Li  Y, Rivers  J, Mathis  S, Li  Z, McGee  L, Chochua  S, et al. Continued increase of erythromycin- and clindamycin-nonsusceptibility among invasive group A streptococci driven by genomic clusters, USA, 2018–2019. Clin Infect Dis. 2022.
  45. Chochua  S, Metcalf  B, Li  Z, Mathis  S, Tran  T, Rivers  J, et al. Invasive group A streptococcal penicillin binding protein 2× variants associated with reduced susceptibility to β-lactam antibiotics in the United States, 2015–2021. Antimicrob Agents Chemother. 2022;66:e0080222. DOIPubMedGoogle Scholar
  46. National Institute on Drug Abuse. West Virginia: opioid-involved deaths and related harms. 2020 [cited 2022 May 5]. https://nida.nih.gov/drug-topics/opioids/opioid-summaries-by-state/west-virginia-opioid-involved-deaths-related-harms
  47. Imtiaz  S, Nafeh  F, Russell  C, Ali  F, Elton-Marshall  T, Rehm  J. The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data. Subst Abuse Treat Prev Policy. 2021;16:87. DOIPubMedGoogle Scholar
  48. Simha  S, Ahmed  Y, Brummett  CM, Waljee  JF, Englesbe  MJ, Bicket  MC. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review. Reg Anesth Pain Med. 2023;48:37–43. DOIPubMedGoogle Scholar
  49. McRae  M, Sardiwalla  Y, Nachmani  O, Price  E, Huynh  M, Coroneos  C. Upper extremity infection related to intravenous drug use: considering the true cost of the COVID-19 pandemic and lockdown. Hand (N Y). 2022;15589447221077377; Epub ahead of print. DOIPubMedGoogle Scholar
  50. United States Interagency Council on Homelessness. West Virginia homelessness statistics. 2020 [cited 2022 May 5]. https://www.usich.gov/homelessness-statistics/wv

Main Article

1These senior authors contributed equally to this article.

Page created: March 06, 2023
Page updated: April 14, 2023
Page reviewed: April 14, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external